Solesence Inc

Solesence Inc(SLSN)股票分析

$0.867

-0.045 (-5.16%)收盤時

Loading chart…
最高
0.885
開盤
0.881
成交量加權均價
0.87
成交量
25.11K
市值
—
最低
0.855
成交金額
21.82K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.

AI 分析 of Solesence Inc (SLSN)

買進

Solesence, Inc. appears to be a good buy right now due to its recent price momentum and improving gross margins. The current price is $0.86, with a recent 5-day change of +11.14%, indicating positive short-term performance. Additionally, the gross margin has improved to 30.97% in Q2 2026, up from 28.87% in Q2 2025, reflecting better cost management. However, the main risk is the company's significant year-to-date decline of -42.93%, which highlights volatility and potential challenges ahead.

估值指標

Solesence Inc(SLSN)目前預期本益比為 11.36,5 年平均預期本益比為 6.54。

預期本益比

合理
5 年均值 P/E
6.54
目前P/E
11.36
高估
12.97
低估
0.11

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 SLSN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SLSN

$4.63

情境價格

基

基準

基準 · 50%SLSN

$4.55

情境價格

悲

悲觀

悲觀 · 25%SLSN

$3.96

情境價格

事件時間軸

2026-08-19 (ET)

17:30:00

Solesence Focuses on Operational Execution and Financial Discipline

2026-02-26 (ET)

08:20:00

Solesence Appoints Yoolie Park as VP of Brand Partnerships

2025-11-11 (ET)

07:01:26

Solesence announces Q3 earnings per share of 2 cents, down from 4 cents a year ago.

2025-11-10 (ET)

08:26:47

Solesence names Yoana Dvorzsak as Vice President of Innovation and Product Integrity

2025-09-03 (ET)

08:09:27

Solesence names Kevin Cureton as its new president and CEO.

資訊

SLSN 常見問題 —— 由 Alphio AI 解答

Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active. It operates in the Consumer Non-Cyclicals sector.

Solesence, Inc. appears to be a good buy right now due to its recent price momentum and improving gross margins. The current price is $0.86, with a recent 5-day change of +11.14%, indicating positive short-term performance. Additionally, the gross margin has improved to 30.97% in Q2 2026, up from 28.87% in Q2 2025, reflecting better cost management. However, the main risk is the company's significant year-to-date decline of -42.93%, which highlights volatility and potential challenges ahead.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易